Clinical Trial Update: Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis [Phase 4]

View source ↗

Summary

Phase 4 trial investigating optimized induction regimens of infliximab for adults with acute severe ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Austin Health | Conditions: Ulcerative Colitis | Phase 4 | Status: COMPLETED